DepoMed upgraded By: MarketMinute.com Stock News January 16, 2015 at 18:16 PM EST Roth Capital upgraded DepoMed Inc. (Nasdaq: DEPO) from a Neutral rating to a Buy rating and lifted its price target from $13.50 to $25. The stock price soared $2.55 to close at $20.20. Related Stocks: Depomed Inc